経口ドラッグデリバリーシステムの世界市場

経口ドラッグデリバリーシステムの世界市場は2030年までに58億米ドルに達する見込み

2024年に43億米ドルと推定される経口ドラッグデリバリーシステムの世界市場は、2024年から2030年にかけてCAGR 5.0%で成長し、2030年には58億米ドルに達すると予測されます。本レポートで分析したセグメントの1つであるバッカル錠＆ロゼンジは、CAGR 5.9％を記録し、分析期間終了までに27億米ドルに達すると予測されます。舌下フィルム＆ウエハー分野の成長率は、分析期間中CAGR 4.5％と推定されます。

米国市場は12億米ドルと推定・予測、中国はCAGR 8.1％で成長予測

米国の経口ドラッグデリバリーシステム市場は、2024年に12億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに12億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは8.1%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ2.3％と5.0％と予測されています。欧州では、ドイツがCAGR 3.2%で成長すると予測されています。

世界の経口ドラッグデリバリーシステム市場- 主要動向と促進要因まとめ

経口ドラッグデリバリーシステムとは何か、なぜ現代医療で重要なのか？

経口ドラッグデリバリーシステムは頬の内側にある頬粘膜から投与するように設計された医薬製剤です。この経路は、消化管や肝臓での初回代謝をバイパスし、全身循環に直接薬剤を吸収させることができます。頬からのドラッグデリバリーには、速やかな作用発現、バイオアベイラビリティの向上、投与の容易さなど、いくつかの利点があり、嚥下困難な患者や即効性のある薬物を必要とする患者に理想的です。これらのシステムには、錠剤、フィルム、パッチ、スプレー、ゲルなど様々な形態があり、薬物を持続的に放出するために粘膜表面に付着するように設計されています。頬へのドラッグデリバリーは、ニトログリセリン（狭心症用）、フェンタニル（疼痛管理用）、インスリンなどの薬物や、ホルモン療法、ワクチン、全身性疾患の治療に一般的に使用されています。その非侵襲的な性質と利便性により、従来の経口や注射のルートに代わる魅力的な選択肢となっています。

技術の進歩は経口ドラッグデリバリーシステムをどのように強化しているか？

技術革新は経口ドラッグデリバリーシステムを大きく前進させ、薬物の安定性、吸収率、患者のコンプライアンスを改善しました。粘接着性ポリマーの開発により、製剤が頬粘膜に接着する能力が強化され、接触時間の延長と薬物放出の制御が可能になりました。ナノテクノロジーはドラッグデリバリーの最適化において重要な役割を担っており、ナノ粒子やリポソームは溶解性、バイオアベイラビリティ、標的デリバリーを向上させています。浸透促進剤の進歩により、ペプチドやタンパク質など、従来は粘膜障壁を越えることが課題であった高分子の吸収が促進されています。また、3Dプリンティング技術は、投与量や放出プロファイルの精密な制御を可能にする、頬側ドラッグデリバリーデバイスをカスタマイズするためのツールとして台頭してきています。さらに、薬物放出と患者の服薬アドヒアランスをリアルタイムでモニターするセンサー内蔵のスマート・ドラッグデリバリー・システムの開発も進んでいます。このような技術的な飛躍的進歩により、幅広い治療領域で頬からのドラッグデリバリーの応用の可能性が広がっています。

経口ドラッグデリバリーシステム市場の現在の動向は？

頬からのドラッグデリバリー市場は、非侵襲的で患者に優しい薬物投与方法に対する需要の高まりによってダイナミックな成長を遂げています。個別化医療への注目が高まっており、個々の患者のニーズに合わせたカスタマイズ可能な投与オプションを提供する頬側投与システムが注目されています。生物製剤やペプチドベースの薬剤の台頭は、特に長期的な治療が必要な慢性疾患の場合、注射に代わる方法として頬からのドラッグデリバリーへの関心を高めています。さらに製薬業界は、ワクチン、遺伝子治療、カンナビノイドを含む新規治療薬の頬へのデリバリーを模索しています。また、自己投与や在宅ヘルスケアの動向も市場の成長に寄与しています。規制当局は、患者の転帰を改善する可能性を認識し、合理化された承認経路を通じてバッカル製剤の開発を支援しています。持続可能性も新たな動向であり、環境に優しい包装や生分解性材料が製品設計に取り入れられ、環境への影響を低減しています。

経口ドラッグデリバリーシステム市場の成長はいくつかの要因によって牽引される...

経口ドラッグデリバリーシステム市場の成長は、慢性疾患の増加、即効性のある治療法への需要、非侵襲的なドラッグデリバリー方法への嗜好の高まりなど、いくつかの要因によって牽引されています。粘接着技術やナノキャリアなどの製剤科学における技術の進歩により、頬側製品の有効性と安全性が向上しています。従来の経口薬ではしばしば困難に直面する老年人口の増加が、頬部システムの需要をさらに高めています。さらに、生物製剤の急増と高分子ドラッグの効率的デリバリーの必要性により、腫瘍学、内分泌学、疼痛管理などの分野で頬側投与ルートの応用が拡大しています。医薬品研究開発への投資増と相まって、規制当局の支援が製品イノベーションと市場拡大を加速させています。経口ドラッグデリバリーの利便性は、患者のコンプライアンスと治療成績を改善する可能性と相まって、世界の医薬品業界において重要な成長分野となっています。

セグメント

タイプ（バッカルタブレットおよびロゼンジ、舌下フィルムおよびウエハー、オーラルスプレー）、用途（禁煙用途、疼痛管理用途、狭心症用途、その他用途）、最終用途（病院最終用途、外来最終用途、その他最終用途）

調査対象企業の例

• AbbVie Inc.
• Adare Pharmaceuticals
• Alpex Pharma
• Aptar Pharma
• ARx, LLC
• Bayer AG
• BioDelivery Sciences International, Inc.
• Catalent, Inc.
• Cipla Limited
• Cynapsus Therapeutics Inc.
• Endo Pharmaceuticals plc
• Generex Biotechnology
• GlaxoSmithKline plc
• Haleon
• Indivior Pharmaceuticals
• Johnson & Johnson
• Novartis AG
• Pfizer Inc.
• Sanofi
• Teva Pharmaceutical Industries Ltd.

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、一般的なLLMや業界固有のSLMにクエリーする代わりに、ビデオ記録、ブログ、検索エンジン調査、大量の企業、製品/サービス、市場データなど、世界中の専門家からキュレートされたコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global Buccal Drug Delivery Systems Market to Reach US$5.8 Billion by 2030

The global market for Buccal Drug Delivery Systems estimated at US$4.3 Billion in the year 2024, is expected to reach US$5.8 Billion by 2030, growing at a CAGR of 5.0% over the analysis period 2024-2030. Buccal Tablets & Lozenges, one of the segments analyzed in the report, is expected to record a 5.9% CAGR and reach US$2.7 Billion by the end of the analysis period. Growth in the Sublingual Films & Wafers segment is estimated at 4.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.2 Billion While China is Forecast to Grow at 8.1% CAGR

The Buccal Drug Delivery Systems market in the U.S. is estimated at US$1.2 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.2 Billion by the year 2030 trailing a CAGR of 8.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.3% and 5.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.2% CAGR.

Global Buccal Drug Delivery Systems Market - Key Trends & Drivers Summarized

What Are Buccal Drug Delivery Systems and Why Are They Important in Modern Medicine?

Buccal drug delivery systems are pharmaceutical formulations designed for administration through the buccal mucosa, the inner lining of the cheeks. This route allows for the direct absorption of drugs into the systemic circulation, bypassing the gastrointestinal tract and first-pass metabolism in the liver, which can degrade certain medications. Buccal drug delivery offers several advantages, including rapid onset of action, improved bioavailability, and ease of administration, making it ideal for patients with swallowing difficulties or those requiring fast-acting medication. These systems come in various forms, such as tablets, films, patches, sprays, and gels, designed to adhere to the mucosal surface for sustained drug release. Buccal delivery is commonly used for drugs like nitroglycerin (for angina), fentanyl (for pain management), and insulin, as well as in hormone therapies, vaccines, and treatments for systemic diseases. Its non-invasive nature and convenience make it an attractive alternative to traditional oral and injectable routes.

How Are Technological Advancements Enhancing Buccal Drug Delivery Systems?

Technological innovations have significantly advanced buccal drug delivery systems, improving drug stability, absorption rates, and patient compliance. The development of mucoadhesive polymers has enhanced the ability of formulations to adhere to the buccal mucosa, ensuring prolonged contact time and controlled drug release. Nanotechnology plays a critical role in optimizing drug delivery, with nanoparticles and liposomes improving solubility, bioavailability, and targeted delivery. Advances in permeation enhancers have facilitated the absorption of large molecules, such as peptides and proteins, which traditionally faced challenges in crossing mucosal barriers. 3D printing technology is also emerging as a tool for customizing buccal drug delivery devices, allowing precise control over dosage and release profiles. Furthermore, smart drug delivery systems with integrated sensors are being developed to monitor drug release and patient adherence in real time. These technological breakthroughs are expanding the potential applications of buccal drug delivery across a wide range of therapeutic areas.

What Are the Current Trends in the Buccal Drug Delivery Systems Market?

The buccal drug delivery market is experiencing dynamic growth driven by the increasing demand for non-invasive, patient-friendly drug administration methods. There is a growing focus on personalized medicine, with buccal systems offering customizable dosing options tailored to individual patient needs. The rise of biologics and peptide-based drugs has fueled interest in buccal delivery as an alternative to injections, particularly for chronic conditions requiring long-term treatment. Additionally, the pharmaceutical industry is exploring buccal delivery for novel therapies, including vaccines, gene therapies, and cannabinoids. The trend towards self-administration and home-based healthcare solutions has also contributed to the market’s growth, as buccal systems are easy to use without medical supervision. Regulatory agencies are supporting the development of buccal formulations through streamlined approval pathways, recognizing their potential to improve patient outcomes. Sustainability is another emerging trend, with eco-friendly packaging and biodegradable materials being incorporated into product designs to reduce environmental impact.

The Growth in the Buccal Drug Delivery Systems Market Is Driven by Several Factors…

The growth in the buccal drug delivery systems market is driven by several factors, including the increasing prevalence of chronic diseases, the demand for rapid-onset therapies, and the rising preference for non-invasive drug delivery methods. Technological advancements in formulation science, such as mucoadhesive technologies and nanocarriers, have improved the efficacy and safety of buccal products. The growing geriatric population, which often faces difficulties with traditional oral medications, has further increased demand for buccal systems. Additionally, the surge in biologics and the need for efficient delivery of large-molecule drugs have expanded the application of buccal routes in areas like oncology, endocrinology, and pain management. Regulatory support, coupled with increased investment in pharmaceutical research and development, has accelerated product innovation and market expansion. The convenience of buccal drug delivery, combined with its potential for improved patient compliance and therapeutic outcomes, positions it as a key growth area in the global pharmaceutical landscape.

SCOPE OF STUDY:

The report analyzes the Buccal Drug Delivery Systems market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Buccal Tablets and Lozenges, Sublingual Films and Wafers, Oral Sprays); Application (Smoking Cessation Application, Pain Management Application, Angina Pectoris Application, Other Applications); End-Use (Hospitals End-Use, Ambulatory Centers End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 32 Featured) -

• AbbVie Inc.
• Adare Pharmaceuticals
• Alpex Pharma
• Aptar Pharma
• ARx, LLC
• Bayer AG
• BioDelivery Sciences International, Inc.
• Catalent, Inc.
• Cipla Limited
• Cynapsus Therapeutics Inc.
• Endo Pharmaceuticals plc
• Generex Biotechnology
• GlaxoSmithKline plc
• Haleon
• Indivior Pharmaceuticals
• Johnson & Johnson
• Novartis AG
• Pfizer Inc.
• Sanofi
• Teva Pharmaceutical Industries Ltd.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • Tariff Impact on Global Supply Chain Patterns
  • Buccal Drug Delivery Systems - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Growing Demand for Non-Invasive Drug Delivery Methods Drives Adoption of Buccal Drug Delivery Systems
  • Rising Prevalence of Chronic Conditions Supports Need for Sustained and Controlled Release Therapies via Buccal Route
  • Increasing Geriatric and Pediatric Populations Propel Use of Easy-to-Administer Buccal Dosage Forms
  • Rapid Onset of Action and High Bioavailability of Buccal Delivery Enhances Its Appeal in Pain Management and Cardiovascular Drugs
  • Technological Advancements in Mucoadhesive Polymers Improve Drug Retention and Absorption in Buccal Cavity
  • Growth of Personalized Medicine Drives Demand for Dose-Flexible Buccal Drug Delivery Platforms
  • Expansion of Peptide and Protein-Based Therapeutics Spurs R&D in Buccal Delivery as a Needle-Free Alternative
  • Increased Focus on Patient Compliance and Convenience Supports Market for Oral Mucosal Drug Delivery
  • Emerging Use of Buccal Films, Tablets, Sprays, and Patches in Smoking Cessation and Hormonal Therapies
  • Regulatory Encouragement for Alternative Delivery Routes to Enhance Safety and Efficacy Drives Market Interest
  • Development of Lipophilic and Nanoparticle-Based Buccal Formulations Improves Solubility and Permeability of Poorly Absorbed Drugs
  • Surge in Demand for Emergency Therapeutics (e.g., anti-anginals, anti-epileptics) Boosts Interest in Fast-Acting Buccal Systems
  • Growing Investment in Biologics and Biosimilars Encourages Exploration of Buccal Routes for Protein and Antibody Delivery
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Buccal Drug Delivery Systems Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Buccal Drug Delivery Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Buccal Drug Delivery Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Buccal Drug Delivery Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Buccal Tablets & Lozenges by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Buccal Tablets & Lozenges by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Buccal Tablets & Lozenges by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Sublingual Films & Wafers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Sublingual Films & Wafers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Sublingual Films & Wafers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Oral Sprays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Oral Sprays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Oral Sprays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Ambulatory Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Ambulatory Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Ambulatory Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Smoking Cessation Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Smoking Cessation Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Smoking Cessation Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Pain Management Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Pain Management Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Pain Management Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Angina Pectoris Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Angina Pectoris Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Angina Pectoris Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Buccal Drug Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 35: USA Recent Past, Current & Future Analysis for Buccal Drug Delivery Systems by Type - Buccal Tablets & Lozenges, Sublingual Films & Wafers and Oral Sprays - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 36: USA Historic Review for Buccal Drug Delivery Systems by Type - Buccal Tablets & Lozenges, Sublingual Films & Wafers and Oral Sprays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 37: USA 15-Year Perspective for Buccal Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Buccal Tablets & Lozenges, Sublingual Films & Wafers and Oral Sprays for the Years 2015, 2025 & 2030
  • TABLE 38: USA Recent Past, Current & Future Analysis for Buccal Drug Delivery Systems by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 39: USA Historic Review for Buccal Drug Delivery Systems by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 40: USA 15-Year Perspective for Buccal Drug Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Centers End-Use for the Years 2015, 2025 & 2030
  • TABLE 41: USA Recent Past, Current & Future Analysis for Buccal Drug Delivery Systems by Application - Smoking Cessation Application, Pain Management Application, Angina Pectoris Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 42: USA Historic Review for Buccal Drug Delivery Systems by Application - Smoking Cessation Application, Pain Management Application, Angina Pectoris Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 43: USA 15-Year Perspective for Buccal Drug Delivery Systems by Application - Percentage Breakdown of Value Sales for Smoking Cessation Application, Pain Management Application, Angina Pectoris Application and Other Applications for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 44: Canada Recent Past, Current & Future Analysis for Buccal Drug Delivery Systems by Type - Buccal Tablets & Lozenges, Sublingual Films & Wafers and Oral Sprays - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 45: Canada Historic Review for Buccal Drug Delivery Systems by Type - Buccal Tablets & Lozenges, Sublingual Films & Wafers and Oral Sprays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 46: Canada 15-Year Perspective for Buccal Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Buccal Tablets & Lozenges, Sublingual Films & Wafers and Oral Sprays for the Years 2015, 2025 & 2030
  • TABLE 47: Canada Recent Past, Current & Future Analysis for Buccal Drug Delivery Systems by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 48: Canada Historic Review for Buccal Drug Delivery Systems by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 49: Canada 15-Year Perspective for Buccal Drug Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Centers End-Use for the Years 2015, 2025 & 2030
  • TABLE 50: Canada Recent Past, Current & Future Analysis for Buccal Drug Delivery Systems by Application - Smoking Cessation Application, Pain Management Application, Angina Pectoris Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Canada Historic Review for Buccal Drug Delivery Systems by Application - Smoking Cessation Application, Pain Management Application, Angina Pectoris Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 52: Canada 15-Year Perspective for Buccal Drug Delivery Systems by Application - Percentage Breakdown of Value Sales for Smoking Cessation Application, Pain Management Application, Angina Pectoris Application and Other Applications for the Years 2015, 2025 & 2030
• JAPAN
  • Buccal Drug Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 53: Japan Recent Past, Current & Future Analysis for Buccal Drug Delivery Systems by Type - Buccal Tablets & Lozenges, Sublingual Films & Wafers and Oral Sprays - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Japan Historic Review for Buccal Drug Delivery Systems by Type - Buccal Tablets & Lozenges, Sublingual Films & Wafers and Oral Sprays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 55: Japan 15-Year Perspective for Buccal Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Buccal Tablets & Lozenges, Sublingual Films & Wafers and Oral Sprays for the Years 2015, 2025 & 2030
  • TABLE 56: Japan Recent Past, Current & Future Analysis for Buccal Drug Delivery Systems by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Japan Historic Review for Buccal Drug Delivery Systems by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 58: Japan 15-Year Perspective for Buccal Drug Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Centers End-Use for the Years 2015, 2025 & 2030
  • TABLE 59: Japan Recent Past, Current & Future Analysis for Buccal Drug Delivery Systems by Application - Smoking Cessation Application, Pain Management Application, Angina Pectoris Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Japan Historic Review for Buccal Drug Delivery Systems by Application - Smoking Cessation Application, Pain Management Application, Angina Pectoris Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 61: Japan 15-Year Perspective for Buccal Drug Delivery Systems by Application - Percentage Breakdown of Value Sales for Smoking Cessation Application, Pain Management Application, Angina Pectoris Application and Other Applications for the Years 2015, 2025 & 2030
• CHINA
  • Buccal Drug Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 62: China Recent Past, Current & Future Analysis for Buccal Drug Delivery Systems by Type - Buccal Tablets & Lozenges, Sublingual Films & Wafers and Oral Sprays - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: China Historic Review for Buccal Drug Delivery Systems by Type - Buccal Tablets & Lozenges, Sublingual Films & Wafers and Oral Sprays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 64: China 15-Year Perspective for Buccal Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Buccal Tablets & Lozenges, Sublingual Films & Wafers and Oral Sprays for the Years 2015, 2025 & 2030
  • TABLE 65: China Recent Past, Current & Future Analysis for Buccal Drug Delivery Systems by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: China Historic Review for Buccal Drug Delivery Systems by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 67: China 15-Year Perspective for Buccal Drug Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Centers End-Use for the Years 2015, 2025 & 2030
  • TABLE 68: China Recent Past, Current & Future Analysis for Buccal Drug Delivery Systems by Application - Smoking Cessation Application, Pain Management Application, Angina Pectoris Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: China Historic Review for Buccal Drug Delivery Systems by Application - Smoking Cessation Application, Pain Management Application, Angina Pectoris Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 70: China 15-Year Perspective for Buccal Drug Delivery Systems by Application - Percentage Breakdown of Value Sales for Smoking Cessation Application, Pain Management Application, Angina Pectoris Application and Other Applications for the Years 2015, 2025 & 2030
• EUROPE
  • Buccal Drug Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 71: Europe Recent Past, Current & Future Analysis for Buccal Drug Delivery Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 72: Europe Historic Review for Buccal Drug Delivery Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 73: Europe 15-Year Perspective for Buccal Drug Delivery Systems by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 74: Europe Recent Past, Current & Future Analysis for Buccal Drug Delivery Systems by Type - Buccal Tablets & Lozenges, Sublingual Films & Wafers and Oral Sprays - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Europe Historic Review for Buccal Drug Delivery Systems by Type - Buccal Tablets & Lozenges, Sublingual Films & Wafers and Oral Sprays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 76: Europe 15-Year Perspective for Buccal Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Buccal Tablets & Lozenges, Sublingual Films & Wafers and Oral Sprays for the Years 2015, 2025 & 2030
  • TABLE 77: Europe Recent Past, Current & Future Analysis for Buccal Drug Delivery Systems by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 78: Europe Historic Review for Buccal Drug Delivery Systems by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 79: Europe 15-Year Perspective for Buccal Drug Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Centers End-Use for the Years 2015, 2025 & 2030
  • TABLE 80: Europe Recent Past, Current & Future Analysis for Buccal Drug Delivery Systems by Application - Smoking Cessation Application, Pain Management Application, Angina Pectoris Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: Europe Historic Review for Buccal Drug Delivery Systems by Application - Smoking Cessation Application, Pain Management Application, Angina Pectoris Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 82: Europe 15-Year Perspective for Buccal Drug Delivery Systems by Application - Percentage Breakdown of Value Sales for Smoking Cessation Application, Pain Management Application, Angina Pectoris Application and Other Applications for the Years 2015, 2025 & 2030
• FRANCE
  • Buccal Drug Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 83: France Recent Past, Current & Future Analysis for Buccal Drug Delivery Systems by Type - Buccal Tablets & Lozenges, Sublingual Films & Wafers and Oral Sprays - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: France Historic Review for Buccal Drug Delivery Systems by Type - Buccal Tablets & Lozenges, Sublingual Films & Wafers and Oral Sprays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 85: France 15-Year Perspective for Buccal Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Buccal Tablets & Lozenges, Sublingual Films & Wafers and Oral Sprays for the Years 2015, 2025 & 2030
  • TABLE 86: France Recent Past, Current & Future Analysis for Buccal Drug Delivery Systems by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: France Historic Review for Buccal Drug Delivery Systems by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 88: France 15-Year Perspective for Buccal Drug Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Centers End-Use for the Years 2015, 2025 & 2030
  • TABLE 89: France Recent Past, Current & Future Analysis for Buccal Drug Delivery Systems by Application - Smoking Cessation Application, Pain Management Application, Angina Pectoris Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: France Historic Review for Buccal Drug Delivery Systems by Application - Smoking Cessation Application, Pain Management Application, Angina Pectoris Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 91: France 15-Year Perspective for Buccal Drug Delivery Systems by Application - Percentage Breakdown of Value Sales for Smoking Cessation Application, Pain Management Application, Angina Pectoris Application and Other Applications for the Years 2015, 2025 & 2030
• GERMANY
  • Buccal Drug Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 92: Germany Recent Past, Current & Future Analysis for Buccal Drug Delivery Systems by Type - Buccal Tablets & Lozenges, Sublingual Films & Wafers and Oral Sprays - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Germany Historic Review for Buccal Drug Delivery Systems by Type - Buccal Tablets & Lozenges, Sublingual Films & Wafers and Oral Sprays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 94: Germany 15-Year Perspective for Buccal Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Buccal Tablets & Lozenges, Sublingual Films & Wafers and Oral Sprays for the Years 2015, 2025 & 2030
  • TABLE 95: Germany Recent Past, Current & Future Analysis for Buccal Drug Delivery Systems by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Germany Historic Review for Buccal Drug Delivery Systems by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 97: Germany 15-Year Perspective for Buccal Drug Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Centers End-Use for the Years 2015, 2025 & 2030
  • TABLE 98: Germany Recent Past, Current & Future Analysis for Buccal Drug Delivery Systems by Application - Smoking Cessation Application, Pain Management Application, Angina Pectoris Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Germany Historic Review for Buccal Drug Delivery Systems by Application - Smoking Cessation Application, Pain Management Application, Angina Pectoris Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 100: Germany 15-Year Perspective for Buccal Drug Delivery Systems by Application - Percentage Breakdown of Value Sales for Smoking Cessation Application, Pain Management Application, Angina Pectoris Application and Other Applications for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 101: Italy Recent Past, Current & Future Analysis for Buccal Drug Delivery Systems by Type - Buccal Tablets & Lozenges, Sublingual Films & Wafers and Oral Sprays - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Italy Historic Review for Buccal Drug Delivery Systems by Type - Buccal Tablets & Lozenges, Sublingual Films & Wafers and Oral Sprays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 103: Italy 15-Year Perspective for Buccal Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Buccal Tablets & Lozenges, Sublingual Films & Wafers and Oral Sprays for the Years 2015, 2025 & 2030
  • TABLE 104: Italy Recent Past, Current & Future Analysis for Buccal Drug Delivery Systems by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Italy Historic Review for Buccal Drug Delivery Systems by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 106: Italy 15-Year Perspective for Buccal Drug Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Centers End-Use for the Years 2015, 2025 & 2030
  • TABLE 107: Italy Recent Past, Current & Future Analysis for Buccal Drug Delivery Systems by Application - Smoking Cessation Application, Pain Management Application, Angina Pectoris Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Italy Historic Review for Buccal Drug Delivery Systems by Application - Smoking Cessation Application, Pain Management Application, Angina Pectoris Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 109: Italy 15-Year Perspective for Buccal Drug Delivery Systems by Application - Percentage Breakdown of Value Sales for Smoking Cessation Application, Pain Management Application, Angina Pectoris Application and Other Applications for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Buccal Drug Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 110: UK Recent Past, Current & Future Analysis for Buccal Drug Delivery Systems by Type - Buccal Tablets & Lozenges, Sublingual Films & Wafers and Oral Sprays - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: UK Historic Review for Buccal Drug Delivery Systems by Type - Buccal Tablets & Lozenges, Sublingual Films & Wafers and Oral Sprays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 112: UK 15-Year Perspective for Buccal Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Buccal Tablets & Lozenges, Sublingual Films & Wafers and Oral Sprays for the Years 2015, 2025 & 2030
  • TABLE 113: UK Recent Past, Current & Future Analysis for Buccal Drug Delivery Systems by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: UK Historic Review for Buccal Drug Delivery Systems by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 115: UK 15-Year Perspective for Buccal Drug Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Centers End-Use for the Years 2015, 2025 & 2030
  • TABLE 116: UK Recent Past, Current & Future Analysis for Buccal Drug Delivery Systems by Application - Smoking Cessation Application, Pain Management Application, Angina Pectoris Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: UK Historic Review for Buccal Drug Delivery Systems by Application - Smoking Cessation Application, Pain Management Application, Angina Pectoris Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 118: UK 15-Year Perspective for Buccal Drug Delivery Systems by Application - Percentage Breakdown of Value Sales for Smoking Cessation Application, Pain Management Application, Angina Pectoris Application and Other Applications for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 119: Spain Recent Past, Current & Future Analysis for Buccal Drug Delivery Systems by Type - Buccal Tablets & Lozenges, Sublingual Films & Wafers and Oral Sprays - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Spain Historic Review for Buccal Drug Delivery Systems by Type - Buccal Tablets & Lozenges, Sublingual Films & Wafers and Oral Sprays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 121: Spain 15-Year Perspective for Buccal Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Buccal Tablets & Lozenges, Sublingual Films & Wafers and Oral Sprays for the Years 2015, 2025 & 2030
  • TABLE 122: Spain Recent Past, Current & Future Analysis for Buccal Drug Delivery Systems by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Spain Historic Review for Buccal Drug Delivery Systems by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 124: Spain 15-Year Perspective for Buccal Drug Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Centers End-Use for the Years 2015, 2025 & 2030
  • TABLE 125: Spain Recent Past, Current & Future Analysis for Buccal Drug Delivery Systems by Application - Smoking Cessation Application, Pain Management Application, Angina Pectoris Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Spain Historic Review for Buccal Drug Delivery Systems by Application - Smoking Cessation Application, Pain Management Application, Angina Pectoris Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 127: Spain 15-Year Perspective for Buccal Drug Delivery Systems by Application - Percentage Breakdown of Value Sales for Smoking Cessation Application, Pain Management Application, Angina Pectoris Application and Other Applications for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 128: Russia Recent Past, Current & Future Analysis for Buccal Drug Delivery Systems by Type - Buccal Tablets & Lozenges, Sublingual Films & Wafers and Oral Sprays - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Russia Historic Review for Buccal Drug Delivery Systems by Type - Buccal Tablets & Lozenges, Sublingual Films & Wafers and Oral Sprays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 130: Russia 15-Year Perspective for Buccal Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Buccal Tablets & Lozenges, Sublingual Films & Wafers and Oral Sprays for the Years 2015, 2025 & 2030
  • TABLE 131: Russia Recent Past, Current & Future Analysis for Buccal Drug Delivery Systems by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Russia Historic Review for Buccal Drug Delivery Systems by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 133: Russia 15-Year Perspective for Buccal Drug Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Centers End-Use for the Years 2015, 2025 & 2030
  • TABLE 134: Russia Recent Past, Current & Future Analysis for Buccal Drug Delivery Systems by Application - Smoking Cessation Application, Pain Management Application, Angina Pectoris Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Russia Historic Review for Buccal Drug Delivery Systems by Application - Smoking Cessation Application, Pain Management Application, Angina Pectoris Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 136: Russia 15-Year Perspective for Buccal Drug Delivery Systems by Application - Percentage Breakdown of Value Sales for Smoking Cessation Application, Pain Management Application, Angina Pectoris Application and Other Applications for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Buccal Drug Delivery Systems by Type - Buccal Tablets & Lozenges, Sublingual Films & Wafers and Oral Sprays - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Rest of Europe Historic Review for Buccal Drug Delivery Systems by Type - Buccal Tablets & Lozenges, Sublingual Films & Wafers and Oral Sprays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 139: Rest of Europe 15-Year Perspective for Buccal Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Buccal Tablets & Lozenges, Sublingual Films & Wafers and Oral Sprays for the Years 2015, 2025 & 2030
  • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Buccal Drug Delivery Systems by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Rest of Europe Historic Review for Buccal Drug Delivery Systems by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 142: Rest of Europe 15-Year Perspective for Buccal Drug Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Centers End-Use for the Years 2015, 2025 & 2030
  • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Buccal Drug Delivery Systems by Application - Smoking Cessation Application, Pain Management Application, Angina Pectoris Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Rest of Europe Historic Review for Buccal Drug Delivery Systems by Application - Smoking Cessation Application, Pain Management Application, Angina Pectoris Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 145: Rest of Europe 15-Year Perspective for Buccal Drug Delivery Systems by Application - Percentage Breakdown of Value Sales for Smoking Cessation Application, Pain Management Application, Angina Pectoris Application and Other Applications for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Buccal Drug Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Buccal Drug Delivery Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 147: Asia-Pacific Historic Review for Buccal Drug Delivery Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 148: Asia-Pacific 15-Year Perspective for Buccal Drug Delivery Systems by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Buccal Drug Delivery Systems by Type - Buccal Tablets & Lozenges, Sublingual Films & Wafers and Oral Sprays - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Asia-Pacific Historic Review for Buccal Drug Delivery Systems by Type - Buccal Tablets & Lozenges, Sublingual Films & Wafers and Oral Sprays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 151: Asia-Pacific 15-Year Perspective for Buccal Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Buccal Tablets & Lozenges, Sublingual Films & Wafers and Oral Sprays for the Years 2015, 2025 & 2030
  • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Buccal Drug Delivery Systems by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Asia-Pacific Historic Review for Buccal Drug Delivery Systems by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 154: Asia-Pacific 15-Year Perspective for Buccal Drug Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Centers End-Use for the Years 2015, 2025 & 2030
  • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Buccal Drug Delivery Systems by Application - Smoking Cessation Application, Pain Management Application, Angina Pectoris Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Asia-Pacific Historic Review for Buccal Drug Delivery Systems by Application - Smoking Cessation Application, Pain Management Application, Angina Pectoris Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 157: Asia-Pacific 15-Year Perspective for Buccal Drug Delivery Systems by Application - Percentage Breakdown of Value Sales for Smoking Cessation Application, Pain Management Application, Angina Pectoris Application and Other Applications for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Buccal Drug Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 158: Australia Recent Past, Current & Future Analysis for Buccal Drug Delivery Systems by Type - Buccal Tablets & Lozenges, Sublingual Films & Wafers and Oral Sprays - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Australia Historic Review for Buccal Drug Delivery Systems by Type - Buccal Tablets & Lozenges, Sublingual Films & Wafers and Oral Sprays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 160: Australia 15-Year Perspective for Buccal Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Buccal Tablets & Lozenges, Sublingual Films & Wafers and Oral Sprays for the Years 2015, 2025 & 2030
  • TABLE 161: Australia Recent Past, Current & Future Analysis for Buccal Drug Delivery Systems by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Australia Historic Review for Buccal Drug Delivery Systems by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 163: Australia 15-Year Perspective for Buccal Drug Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Centers End-Use for the Years 2015, 2025 & 2030
  • TABLE 164: Australia Recent Past, Current & Future Analysis for Buccal Drug Delivery Systems by Application - Smoking Cessation Application, Pain Management Application, Angina Pectoris Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Australia Historic Review for Buccal Drug Delivery Systems by Application - Smoking Cessation Application, Pain Management Application, Angina Pectoris Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 166: Australia 15-Year Perspective for Buccal Drug Delivery Systems by Application - Percentage Breakdown of Value Sales for Smoking Cessation Application, Pain Management Application, Angina Pectoris Application and Other Applications for the Years 2015, 2025 & 2030
• INDIA
  • Buccal Drug Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 167: India Recent Past, Current & Future Analysis for Buccal Drug Delivery Systems by Type - Buccal Tablets & Lozenges, Sublingual Films & Wafers and Oral Sprays - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: India Historic Review for Buccal Drug Delivery Systems by Type - Buccal Tablets & Lozenges, Sublingual Films & Wafers and Oral Sprays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 169: India 15-Year Perspective for Buccal Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Buccal Tablets & Lozenges, Sublingual Films & Wafers and Oral Sprays for the Years 2015, 2025 & 2030
  • TABLE 170: India Recent Past, Current & Future Analysis for Buccal Drug Delivery Systems by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: India Historic Review for Buccal Drug Delivery Systems by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 172: India 15-Year Perspective for Buccal Drug Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Centers End-Use for the Years 2015, 2025 & 2030
  • TABLE 173: India Recent Past, Current & Future Analysis for Buccal Drug Delivery Systems by Application - Smoking Cessation Application, Pain Management Application, Angina Pectoris Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: India Historic Review for Buccal Drug Delivery Systems by Application - Smoking Cessation Application, Pain Management Application, Angina Pectoris Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 175: India 15-Year Perspective for Buccal Drug Delivery Systems by Application - Percentage Breakdown of Value Sales for Smoking Cessation Application, Pain Management Application, Angina Pectoris Application and Other Applications for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 176: South Korea Recent Past, Current & Future Analysis for Buccal Drug Delivery Systems by Type - Buccal Tablets & Lozenges, Sublingual Films & Wafers and Oral Sprays - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: South Korea Historic Review for Buccal Drug Delivery Systems by Type - Buccal Tablets & Lozenges, Sublingual Films & Wafers and Oral Sprays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 178: South Korea 15-Year Perspective for Buccal Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Buccal Tablets & Lozenges, Sublingual Films & Wafers and Oral Sprays for the Years 2015, 2025 & 2030
  • TABLE 179: South Korea Recent Past, Current & Future Analysis for Buccal Drug Delivery Systems by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: South Korea Historic Review for Buccal Drug Delivery Systems by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 181: South Korea 15-Year Perspective for Buccal Drug Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Centers End-Use for the Years 2015, 2025 & 2030
  • TABLE 182: South Korea Recent Past, Current & Future Analysis for Buccal Drug Delivery Systems by Application - Smoking Cessation Application, Pain Management Application, Angina Pectoris Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: South Korea Historic Review for Buccal Drug Delivery Systems by Application - Smoking Cessation Application, Pain Management Application, Angina Pectoris Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 184: South Korea 15-Year Perspective for Buccal Drug Delivery Systems by Application - Percentage Breakdown of Value Sales for Smoking Cessation Application, Pain Management Application, Angina Pectoris Application and Other Applications for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Buccal Drug Delivery Systems by Type - Buccal Tablets & Lozenges, Sublingual Films & Wafers and Oral Sprays - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Rest of Asia-Pacific Historic Review for Buccal Drug Delivery Systems by Type - Buccal Tablets & Lozenges, Sublingual Films & Wafers and Oral Sprays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 187: Rest of Asia-Pacific 15-Year Perspective for Buccal Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Buccal Tablets & Lozenges, Sublingual Films & Wafers and Oral Sprays for the Years 2015, 2025 & 2030
  • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Buccal Drug Delivery Systems by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Rest of Asia-Pacific Historic Review for Buccal Drug Delivery Systems by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 190: Rest of Asia-Pacific 15-Year Perspective for Buccal Drug Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Centers End-Use for the Years 2015, 2025 & 2030
  • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Buccal Drug Delivery Systems by Application - Smoking Cessation Application, Pain Management Application, Angina Pectoris Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Rest of Asia-Pacific Historic Review for Buccal Drug Delivery Systems by Application - Smoking Cessation Application, Pain Management Application, Angina Pectoris Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 193: Rest of Asia-Pacific 15-Year Perspective for Buccal Drug Delivery Systems by Application - Percentage Breakdown of Value Sales for Smoking Cessation Application, Pain Management Application, Angina Pectoris Application and Other Applications for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Buccal Drug Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 194: Latin America Recent Past, Current & Future Analysis for Buccal Drug Delivery Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 195: Latin America Historic Review for Buccal Drug Delivery Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 196: Latin America 15-Year Perspective for Buccal Drug Delivery Systems by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 197: Latin America Recent Past, Current & Future Analysis for Buccal Drug Delivery Systems by Type - Buccal Tablets & Lozenges, Sublingual Films & Wafers and Oral Sprays - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Latin America Historic Review for Buccal Drug Delivery Systems by Type - Buccal Tablets & Lozenges, Sublingual Films & Wafers and Oral Sprays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 199: Latin America 15-Year Perspective for Buccal Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Buccal Tablets & Lozenges, Sublingual Films & Wafers and Oral Sprays for the Years 2015, 2025 & 2030
  • TABLE 200: Latin America Recent Past, Current & Future Analysis for Buccal Drug Delivery Systems by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Latin America Historic Review for Buccal Drug Delivery Systems by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 202: Latin America 15-Year Perspective for Buccal Drug Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Centers End-Use for the Years 2015, 2025 & 2030
  • TABLE 203: Latin America Recent Past, Current & Future Analysis for Buccal Drug Delivery Systems by Application - Smoking Cessation Application, Pain Management Application, Angina Pectoris Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Latin America Historic Review for Buccal Drug Delivery Systems by Application - Smoking Cessation Application, Pain Management Application, Angina Pectoris Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 205: Latin America 15-Year Perspective for Buccal Drug Delivery Systems by Application - Percentage Breakdown of Value Sales for Smoking Cessation Application, Pain Management Application, Angina Pectoris Application and Other Applications for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 206: Argentina Recent Past, Current & Future Analysis for Buccal Drug Delivery Systems by Type - Buccal Tablets & Lozenges, Sublingual Films & Wafers and Oral Sprays - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Argentina Historic Review for Buccal Drug Delivery Systems by Type - Buccal Tablets & Lozenges, Sublingual Films & Wafers and Oral Sprays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 208: Argentina 15-Year Perspective for Buccal Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Buccal Tablets & Lozenges, Sublingual Films & Wafers and Oral Sprays for the Years 2015, 2025 & 2030
  • TABLE 209: Argentina Recent Past, Current & Future Analysis for Buccal Drug Delivery Systems by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Argentina Historic Review for Buccal Drug Delivery Systems by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 211: Argentina 15-Year Perspective for Buccal Drug Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Centers End-Use for the Years 2015, 2025 & 2030
  • TABLE 212: Argentina Recent Past, Current & Future Analysis for Buccal Drug Delivery Systems by Application - Smoking Cessation Application, Pain Management Application, Angina Pectoris Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Argentina Historic Review for Buccal Drug Delivery Systems by Application - Smoking Cessation Application, Pain Management Application, Angina Pectoris Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 214: Argentina 15-Year Perspective for Buccal Drug Delivery Systems by Application - Percentage Breakdown of Value Sales for Smoking Cessation Application, Pain Management Application, Angina Pectoris Application and Other Applications for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 215: Brazil Recent Past, Current & Future Analysis for Buccal Drug Delivery Systems by Type - Buccal Tablets & Lozenges, Sublingual Films & Wafers and Oral Sprays - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Brazil Historic Review for Buccal Drug Delivery Systems by Type - Buccal Tablets & Lozenges, Sublingual Films & Wafers and Oral Sprays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 217: Brazil 15-Year Perspective for Buccal Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Buccal Tablets & Lozenges, Sublingual Films & Wafers and Oral Sprays for the Years 2015, 2025 & 2030
  • TABLE 218: Brazil Recent Past, Current & Future Analysis for Buccal Drug Delivery Systems by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Brazil Historic Review for Buccal Drug Delivery Systems by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 220: Brazil 15-Year Perspective for Buccal Drug Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Centers End-Use for the Years 2015, 2025 & 2030
  • TABLE 221: Brazil Recent Past, Current & Future Analysis for Buccal Drug Delivery Systems by Application - Smoking Cessation Application, Pain Management Application, Angina Pectoris Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Brazil Historic Review for Buccal Drug Delivery Systems by Application - Smoking Cessation Application, Pain Management Application, Angina Pectoris Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 223: Brazil 15-Year Perspective for Buccal Drug Delivery Systems by Application - Percentage Breakdown of Value Sales for Smoking Cessation Application, Pain Management Application, Angina Pectoris Application and Other Applications for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 224: Mexico Recent Past, Current & Future Analysis for Buccal Drug Delivery Systems by Type - Buccal Tablets & Lozenges, Sublingual Films & Wafers and Oral Sprays - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Mexico Historic Review for Buccal Drug Delivery Systems by Type - Buccal Tablets & Lozenges, Sublingual Films & Wafers and Oral Sprays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 226: Mexico 15-Year Perspective for Buccal Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Buccal Tablets & Lozenges, Sublingual Films & Wafers and Oral Sprays for the Years 2015, 2025 & 2030
  • TABLE 227: Mexico Recent Past, Current & Future Analysis for Buccal Drug Delivery Systems by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Mexico Historic Review for Buccal Drug Delivery Systems by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 229: Mexico 15-Year Perspective for Buccal Drug Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Centers End-Use for the Years 2015, 2025 & 2030
  • TABLE 230: Mexico Recent Past, Current & Future Analysis for Buccal Drug Delivery Systems by Application - Smoking Cessation Application, Pain Management Application, Angina Pectoris Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Mexico Historic Review for Buccal Drug Delivery Systems by Application - Smoking Cessation Application, Pain Management Application, Angina Pectoris Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 232: Mexico 15-Year Perspective for Buccal Drug Delivery Systems by Application - Percentage Breakdown of Value Sales for Smoking Cessation Application, Pain Management Application, Angina Pectoris Application and Other Applications for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Buccal Drug Delivery Systems by Type - Buccal Tablets & Lozenges, Sublingual Films & Wafers and Oral Sprays - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Rest of Latin America Historic Review for Buccal Drug Delivery Systems by Type - Buccal Tablets & Lozenges, Sublingual Films & Wafers and Oral Sprays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 235: Rest of Latin America 15-Year Perspective for Buccal Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Buccal Tablets & Lozenges, Sublingual Films & Wafers and Oral Sprays for the Years 2015, 2025 & 2030
  • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Buccal Drug Delivery Systems by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Rest of Latin America Historic Review for Buccal Drug Delivery Systems by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 238: Rest of Latin America 15-Year Perspective for Buccal Drug Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Centers End-Use for the Years 2015, 2025 & 2030
  • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Buccal Drug Delivery Systems by Application - Smoking Cessation Application, Pain Management Application, Angina Pectoris Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Rest of Latin America Historic Review for Buccal Drug Delivery Systems by Application - Smoking Cessation Application, Pain Management Application, Angina Pectoris Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 241: Rest of Latin America 15-Year Perspective for Buccal Drug Delivery Systems by Application - Percentage Breakdown of Value Sales for Smoking Cessation Application, Pain Management Application, Angina Pectoris Application and Other Applications for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Buccal Drug Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 242: Middle East Recent Past, Current & Future Analysis for Buccal Drug Delivery Systems by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 243: Middle East Historic Review for Buccal Drug Delivery Systems by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 244: Middle East 15-Year Perspective for Buccal Drug Delivery Systems by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 245: Middle East Recent Past, Current & Future Analysis for Buccal Drug Delivery Systems by Type - Buccal Tablets & Lozenges, Sublingual Films & Wafers and Oral Sprays - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Middle East Historic Review for Buccal Drug Delivery Systems by Type - Buccal Tablets & Lozenges, Sublingual Films & Wafers and Oral Sprays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 247: Middle East 15-Year Perspective for Buccal Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Buccal Tablets & Lozenges, Sublingual Films & Wafers and Oral Sprays for the Years 2015, 2025 & 2030
  • TABLE 248: Middle East Recent Past, Current & Future Analysis for Buccal Drug Delivery Systems by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Middle East Historic Review for Buccal Drug Delivery Systems by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 250: Middle East 15-Year Perspective for Buccal Drug Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Centers End-Use for the Years 2015, 2025 & 2030
  • TABLE 251: Middle East Recent Past, Current & Future Analysis for Buccal Drug Delivery Systems by Application - Smoking Cessation Application, Pain Management Application, Angina Pectoris Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Middle East Historic Review for Buccal Drug Delivery Systems by Application - Smoking Cessation Application, Pain Management Application, Angina Pectoris Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 253: Middle East 15-Year Perspective for Buccal Drug Delivery Systems by Application - Percentage Breakdown of Value Sales for Smoking Cessation Application, Pain Management Application, Angina Pectoris Application and Other Applications for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 254: Iran Recent Past, Current & Future Analysis for Buccal Drug Delivery Systems by Type - Buccal Tablets & Lozenges, Sublingual Films & Wafers and Oral Sprays - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Iran Historic Review for Buccal Drug Delivery Systems by Type - Buccal Tablets & Lozenges, Sublingual Films & Wafers and Oral Sprays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 256: Iran 15-Year Perspective for Buccal Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Buccal Tablets & Lozenges, Sublingual Films & Wafers and Oral Sprays for the Years 2015, 2025 & 2030
  • TABLE 257: Iran Recent Past, Current & Future Analysis for Buccal Drug Delivery Systems by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Iran Historic Review for Buccal Drug Delivery Systems by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 259: Iran 15-Year Perspective for Buccal Drug Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Centers End-Use for the Years 2015, 2025 & 2030
  • TABLE 260: Iran Recent Past, Current & Future Analysis for Buccal Drug Delivery Systems by Application - Smoking Cessation Application, Pain Management Application, Angina Pectoris Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Iran Historic Review for Buccal Drug Delivery Systems by Application - Smoking Cessation Application, Pain Management Application, Angina Pectoris Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 262: Iran 15-Year Perspective for Buccal Drug Delivery Systems by Application - Percentage Breakdown of Value Sales for Smoking Cessation Application, Pain Management Application, Angina Pectoris Application and Other Applications for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 263: Israel Recent Past, Current & Future Analysis for Buccal Drug Delivery Systems by Type - Buccal Tablets & Lozenges, Sublingual Films & Wafers and Oral Sprays - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Israel Historic Review for Buccal Drug Delivery Systems by Type - Buccal Tablets & Lozenges, Sublingual Films & Wafers and Oral Sprays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 265: Israel 15-Year Perspective for Buccal Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Buccal Tablets & Lozenges, Sublingual Films & Wafers and Oral Sprays for the Years 2015, 2025 & 2030
  • TABLE 266: Israel Recent Past, Current & Future Analysis for Buccal Drug Delivery Systems by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Israel Historic Review for Buccal Drug Delivery Systems by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 268: Israel 15-Year Perspective for Buccal Drug Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Centers End-Use for the Years 2015, 2025 & 2030
  • TABLE 269: Israel Recent Past, Current & Future Analysis for Buccal Drug Delivery Systems by Application - Smoking Cessation Application, Pain Management Application, Angina Pectoris Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Israel Historic Review for Buccal Drug Delivery Systems by Application - Smoking Cessation Application, Pain Management Application, Angina Pectoris Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 271: Israel 15-Year Perspective for Buccal Drug Delivery Systems by Application - Percentage Breakdown of Value Sales for Smoking Cessation Application, Pain Management Application, Angina Pectoris Application and Other Applications for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Buccal Drug Delivery Systems by Type - Buccal Tablets & Lozenges, Sublingual Films & Wafers and Oral Sprays - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Saudi Arabia Historic Review for Buccal Drug Delivery Systems by Type - Buccal Tablets & Lozenges, Sublingual Films & Wafers and Oral Sprays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 274: Saudi Arabia 15-Year Perspective for Buccal Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Buccal Tablets & Lozenges, Sublingual Films & Wafers and Oral Sprays for the Years 2015, 2025 & 2030
  • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Buccal Drug Delivery Systems by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Saudi Arabia Historic Review for Buccal Drug Delivery Systems by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 277: Saudi Arabia 15-Year Perspective for Buccal Drug Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Centers End-Use for the Years 2015, 2025 & 2030
  • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Buccal Drug Delivery Systems by Application - Smoking Cessation Application, Pain Management Application, Angina Pectoris Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Saudi Arabia Historic Review for Buccal Drug Delivery Systems by Application - Smoking Cessation Application, Pain Management Application, Angina Pectoris Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 280: Saudi Arabia 15-Year Perspective for Buccal Drug Delivery Systems by Application - Percentage Breakdown of Value Sales for Smoking Cessation Application, Pain Management Application, Angina Pectoris Application and Other Applications for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 281: UAE Recent Past, Current & Future Analysis for Buccal Drug Delivery Systems by Type - Buccal Tablets & Lozenges, Sublingual Films & Wafers and Oral Sprays - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: UAE Historic Review for Buccal Drug Delivery Systems by Type - Buccal Tablets & Lozenges, Sublingual Films & Wafers and Oral Sprays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 283: UAE 15-Year Perspective for Buccal Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Buccal Tablets & Lozenges, Sublingual Films & Wafers and Oral Sprays for the Years 2015, 2025 & 2030
  • TABLE 284: UAE Recent Past, Current & Future Analysis for Buccal Drug Delivery Systems by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: UAE Historic Review for Buccal Drug Delivery Systems by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 286: UAE 15-Year Perspective for Buccal Drug Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Centers End-Use for the Years 2015, 2025 & 2030
  • TABLE 287: UAE Recent Past, Current & Future Analysis for Buccal Drug Delivery Systems by Application - Smoking Cessation Application, Pain Management Application, Angina Pectoris Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: UAE Historic Review for Buccal Drug Delivery Systems by Application - Smoking Cessation Application, Pain Management Application, Angina Pectoris Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 289: UAE 15-Year Perspective for Buccal Drug Delivery Systems by Application - Percentage Breakdown of Value Sales for Smoking Cessation Application, Pain Management Application, Angina Pectoris Application and Other Applications for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Buccal Drug Delivery Systems by Type - Buccal Tablets & Lozenges, Sublingual Films & Wafers and Oral Sprays - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Rest of Middle East Historic Review for Buccal Drug Delivery Systems by Type - Buccal Tablets & Lozenges, Sublingual Films & Wafers and Oral Sprays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 292: Rest of Middle East 15-Year Perspective for Buccal Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Buccal Tablets & Lozenges, Sublingual Films & Wafers and Oral Sprays for the Years 2015, 2025 & 2030
  • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Buccal Drug Delivery Systems by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Rest of Middle East Historic Review for Buccal Drug Delivery Systems by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 295: Rest of Middle East 15-Year Perspective for Buccal Drug Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Centers End-Use for the Years 2015, 2025 & 2030
  • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Buccal Drug Delivery Systems by Application - Smoking Cessation Application, Pain Management Application, Angina Pectoris Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Rest of Middle East Historic Review for Buccal Drug Delivery Systems by Application - Smoking Cessation Application, Pain Management Application, Angina Pectoris Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 298: Rest of Middle East 15-Year Perspective for Buccal Drug Delivery Systems by Application - Percentage Breakdown of Value Sales for Smoking Cessation Application, Pain Management Application, Angina Pectoris Application and Other Applications for the Years 2015, 2025 & 2030
• AFRICA
  • Buccal Drug Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 299: Africa Recent Past, Current & Future Analysis for Buccal Drug Delivery Systems by Type - Buccal Tablets & Lozenges, Sublingual Films & Wafers and Oral Sprays - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Africa Historic Review for Buccal Drug Delivery Systems by Type - Buccal Tablets & Lozenges, Sublingual Films & Wafers and Oral Sprays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 301: Africa 15-Year Perspective for Buccal Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Buccal Tablets & Lozenges, Sublingual Films & Wafers and Oral Sprays for the Years 2015, 2025 & 2030
  • TABLE 302: Africa Recent Past, Current & Future Analysis for Buccal Drug Delivery Systems by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Africa Historic Review for Buccal Drug Delivery Systems by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 304: Africa 15-Year Perspective for Buccal Drug Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Centers End-Use for the Years 2015, 2025 & 2030
  • TABLE 305: Africa Recent Past, Current & Future Analysis for Buccal Drug Delivery Systems by Application - Smoking Cessation Application, Pain Management Application, Angina Pectoris Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Africa Historic Review for Buccal Drug Delivery Systems by Application - Smoking Cessation Application, Pain Management Application, Angina Pectoris Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 307: Africa 15-Year Perspective for Buccal Drug Delivery Systems by Application - Percentage Breakdown of Value Sales for Smoking Cessation Application, Pain Management Application, Angina Pectoris Application and Other Applications for the Years 2015, 2025 & 2030

IV. COMPETITION